retatrutide phase 2 nejm 2023 weight loss percent 48 weeks The loudest people online are always chasing the highest dose. The data doesn't support that. showed up to ~24% at weeks. But here's what actually matters 🚨 Retatrutide Phase 2 is

NEJM SELECT trial (fulltext)

Every platform should uphold dependable support, responsible play tools, and robust payment processes

Myth #11: Its Not FDA Approved So It Must Be Unsafe The Claim: Retatrutide isnt approved yet which proves its dangerous, thats why FDA wont approve it (Facebook comment) The Reality: FDA approval status reflects where in the approval process a medication sits, not a safety judgment

Constipation patterns on Retatrutide differ from other gastrointestinal side effects, which has important implications for how you prepare and respond

This does not mean the medication has failed

Prevention through hydration is the most effective approach for reducing headache frequency